Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

TLRs and chronic inflammation.

Ospelt C, Gay S.

Int J Biochem Cell Biol. 2010 Apr;42(4):495-505. doi: 10.1016/j.biocel.2009.10.010. Review.

PMID:
19840864
2.

The role of toll-like receptors in chronic inflammation.

Drexler SK, Foxwell BM.

Int J Biochem Cell Biol. 2010 Apr;42(4):506-18. doi: 10.1016/j.biocel.2009.10.009. Review.

PMID:
19837184
3.

Activation of the innate immune system in atherosclerotic disease.

Oude Nijhuis MM, van Keulen JK, Pasterkamp G, Quax PH, de Kleijn DP.

Curr Pharm Des. 2007;13(10):983-94. Review.

PMID:
17430162
4.

Direct and indirect role of Toll-like receptors in T cell mediated immunity.

Xu D, Liu H, Komai-Koma M.

Cell Mol Immunol. 2004 Aug;1(4):239-46. Review.

5.
6.

The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.

Lien E, Zipris D.

Curr Mol Med. 2009 Feb;9(1):52-68. Review.

PMID:
19199942
7.

Important aspects of Toll-like receptors, ligands and their signaling pathways.

Chang ZL.

Inflamm Res. 2010 Oct;59(10):791-808. doi: 10.1007/s00011-010-0208-2. Review.

PMID:
20593217
8.

Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease?

Katsargyris A, Klonaris C, Bastounis E, Theocharis S.

Expert Opin Ther Targets. 2008 Nov;12(11):1329-46. doi: 10.1517/14728222.12.11.1329 . Review.

PMID:
18851691
9.

Therapeutic targeting of toll-like receptors in gastrointestinal inflammation.

Ishihara S, Rumi MA, Ortega-Cava CF, Kazumori H, Kadowaki Y, Ishimura N, Kinoshita Y.

Curr Pharm Des. 2006;12(32):4215-28. Review.

PMID:
17100624
10.

The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.

Lin Q, Li M, Fang D, Fang J, Su SB.

Int Immunopharmacol. 2011 Oct;11(10):1422-32. doi: 10.1016/j.intimp.2011.04.026. Review.

PMID:
21600309
11.

Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.

Fukata M, Vamadevan AS, Abreu MT.

Semin Immunol. 2009 Aug;21(4):242-53. doi: 10.1016/j.smim.2009.06.005. Review.

PMID:
19748439
12.

Toll-like receptors and innate immunity.

Kumar H, Kawai T, Akira S.

Biochem Biophys Res Commun. 2009 Oct 30;388(4):621-5. doi: 10.1016/j.bbrc.2009.08.062. Review.

PMID:
19686699
13.

Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.

Ryffel B, Fremond C, Jacobs M, Parida S, Botha T, Schnyder B, Quesniaux V.

Tuberculosis (Edinb). 2005 Sep-Nov;85(5-6):395-405.

PMID:
16257265
14.

[Role of TLR-dependent and independent pathways in autoimmunity].

Kumagai Y, Akira S.

Nihon Rinsho. 2009 Mar;67(3):487-93. Review. Japanese.

PMID:
19280921
15.

Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs.

Becker CE, O'Neill LA.

Semin Immunopathol. 2007 Sep;29(3):239-48. Review.

PMID:
17805544
16.

Toll-like receptors, endogenous ligands, and systemic autoimmune disease.

Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A.

Immunol Rev. 2005 Apr;204:27-42. Review.

PMID:
15790348
17.

Toll-like receptors on the fork roads between innate and adaptive immunity.

Abdelsadik A, Trad A.

Hum Immunol. 2011 Dec;72(12):1188-93. doi: 10.1016/j.humimm.2011.08.015. Review.

PMID:
21920397
18.

Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors.

Albiger B, Dahlberg S, Henriques-Normark B, Normark S.

J Intern Med. 2007 Jun;261(6):511-28. Review.

19.

Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Ofodile ON.

J Ind Microbiol Biotechnol. 2007 Dec;34(12):751-62. Review.

PMID:
17876621
20.

Toll-like receptors in human infectious diseases.

de la Barrera S, Alemán M, Sasiain Mdel C.

Curr Pharm Des. 2006;12(32):4173-84. Review.

PMID:
17100620

Supplemental Content

Support Center